We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Insys Settles U.S. Opioid Fraud Charges for $225 Million
Insys Settles U.S. Opioid Fraud Charges for $225 Million
Insys Therapeutics bribed doctors to prescribe its fentanyl spray, the company admitted as part of a $225 million settlement with the U.S. government, the Department of Justice announced.